Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia

Author(s):  
Paniz Tavakoli Shirazi ◽  
Laura N. Eadie ◽  
Susan L. Heatley ◽  
Elyse C. Page ◽  
Maxime François ◽  
...  
Leukemia ◽  
2019 ◽  
Vol 33 (7) ◽  
pp. 1557-1569 ◽  
Author(s):  
Belen Lopez-Millan ◽  
Diego Sanchéz-Martínez ◽  
Heleia Roca-Ho ◽  
Francisco Gutiérrez-Agüera ◽  
Oscar Molina ◽  
...  

2003 ◽  
Vol 144 (2) ◽  
pp. 143-147 ◽  
Author(s):  
Nathalie Douet-Guilbert ◽  
Frédéric Morel ◽  
Marie-Josée Le Bris ◽  
Angèle Herry ◽  
Geneviève Le Calvez ◽  
...  

Blood ◽  
2012 ◽  
Vol 120 (22) ◽  
pp. 4441-4443 ◽  
Author(s):  
Toby Eyre ◽  
Claire J. Schwab ◽  
Ross Kinstrie ◽  
Ann Keen McGuire ◽  
Jen Strefford ◽  
...  

2015 ◽  
Vol 15 ◽  
pp. S1-S2
Author(s):  
Shubhchintan Randhawa ◽  
Byung Sik Cho ◽  
Dipanjan Ghosh ◽  
Amnon Peled ◽  
Richard E. Davis ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
F. Marchesi ◽  
K. Girardi ◽  
G. Avvisati

Translocation t(4;11)(q21;q23) leading to formation ofMLL-AF4fusion gene is found in about 10% of newly diagnosed B-cell acute lymphoblastic leukemia (ALL) in adult patients. Patients expressing this chromosomal aberration present typical biological, immunophenotypic, and clinical features. This form of leukemia is universally recognized as high-risk leukemia and treatment intensification with allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission (CR) could be a valid option to improve prognosis, but data obtained from the literature are controversial. In this review, we briefly describe pathogenetic, clinical, and prognostic characteristics of adult t(4;11)(q21;q23)/MLL-AF4positive ALL and provide a review of the clinical outcome reported by the most important cooperative groups worldwide.


2019 ◽  
Vol 1 ◽  
pp. 31-33
Author(s):  
Vijay Suri ◽  
Gunjan Bala ◽  
Ramit Gupta ◽  
Shikha Narang ◽  
Anshul Gupta ◽  
...  

Philadelphia chromosome is well-known chromosomal abnormality in chronic myeloid leukemia (CML). However, B-acute lymphoblastic leukemia (B-ALL) with Philadelphia-positive (Ph′) is a neoplasm of lymphoblast committed to the B-cell lineage. The clinical presentation of B-ALL Ph′+ is similar to B-ALL but is more common in adults than in children. Our 50-year-old male patient presented to psychiatry OPD for deaddiction of alcohol. The patient also complained of generalized weakness and pain in legs which may have been due to chronic alcoholism. He was further investigated and diagnosed as B-precursor ALL with positive BCR-ABL fusion gene. Here, we like to emphasize that overlapping symptoms may lead to delay in diagnosis, so clinician should always investigate the patient thoroughly so that the patient is diagnosed on time and treatment can be started as early as possible and fatal outcomes can be avoided.


Sign in / Sign up

Export Citation Format

Share Document